Evidence map›Paper›PMID 40635906›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2025

Where Do Patients With Cirrhosis Die? A CDC WONDER Analysis From 1999 to 2020.

Areej Iftikhar, Fatima Noor Alam, Danish Ali Ashraf, Saad Hassan Qureshi, Muzamil Akhtar, Ayesha Islam Khan, Muhammad Raza, Raheel Qureshi, Raheel Ahmed

Abstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Where Do Patients With Cirrhosis Die? A CDC WONDER Analysis From 1999 to 2020.JGH open : an open access journal of gastroenterology and hepatology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Areej IftikharDepartment of Medicine Allama Iqbal Medical College Lahore Pakistan.
Fatima Noor AlamDepartment of Medicine Services Institute of Medical Sciences Lahore Pakistan.
Danish Ali AshrafDepartment of Medicine Foundation University Medical College Islamabad Pakistan.ORCID https://orcid.org/0000-0002-3013-9359
Saad Hassan QureshiDepartment of Medicine Bahria University Health Sciences Karachi Pakistan.ORCID https://orcid.org/0009-0009-8562-5491
Muzamil AkhtarDepartment of Medicine Gujranwala Medical College Gujranwala Pakistan.ORCID https://orcid.org/0009-0006-3579-9141
Ayesha Islam KhanDepartment of Medicine Allama Iqbal Medical College Lahore Pakistan.
Muhammad RazaDepartment of Medicine Jinnah Sindh Medical University Karachi Pakistan.ORCID https://orcid.org/0009-0009-1326-1895
Raheel QureshiDepartment of Gastroenterology Queen Elizabeth Hospital Gateshead UK.
Raheel AhmedNational Heart and Lung Institute Imperial College London UK.ORCID https://orcid.org/0000-0003-2814-7314

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Liver Cirrhosis is a growing cause of morbidity and mortality worldwide, but significant knowledge gaps remain regarding disparities in the place of patient death. This study aims to analyze the place of death trends for cirrhosis patients in the United States from 1999 to 2020, to direct preventive and palliative care measures. Methods: In this descriptive study, death certificates were examined using the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) database, using ICD codes K70.3, K71.7, and K74. The variables studied were the year, sex, age, race, rural-urban, census regions, and state. Percentages of deaths in each location were trended over time for interpretation. Results: Between 1999 and 2020, a total of 1 090 420 deaths were attributed to cirrhosis. The majority of these fatalities occurred in inpatient medical facilities (48.75%), followed by the decedent's home (25.71%). Men consistently exhibited higher deaths in all settings, especially in medical facility-inpatient settings (31.39%), and the highest deaths were for the 55-64 age group. NH White population reported the highest mortality in all places of death, whereas the South led mortality records among census regions. The least deaths occurred in non-core (non-metro) areas, and state-wise analysis revealed California to have the highest number of deaths (75 723), seconded by Texas (55 447). Conclusion: Mortality due to cirrhosis increased gradually from 1999 to 2019, with a steep rise observed in 2019-2020. Men, the White race, 55-65 years age bracket, and residents of rural and Southern census regions reported the highest number of deaths from cirrhosis.

Indexed as

disparitiesliver cirrhosismortality trendsplace of death

Identifiers

PMID40635906
PMCPMC12238664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.